These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32798188)

  • 1. Percent reduction of the ulcer size at 4 weeks is a predictor of the complete healing of endoscopic submucosal dissection-induced gastric ulcers.
    Uchida E; Kato S; Tsuchiya I; Ohkuma K; Taniguchi L; Tanida E; Masui Y; Yoshizawa K; Nakajima A; Izumi M
    Arab J Gastroenterol; 2020 Sep; 21(3):183-188. PubMed ID: 32798188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis.
    Maruoka D; Arai M; Kasamatsu S; Ishigami H; Taida T; Okimoto K; Saito K; Matsumura T; Nakagawa T; Katsuno T; Yokosuka O
    Dig Endosc; 2017 Jan; 29(1):57-64. PubMed ID: 27492962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
    Ichida T; Ueyama S; Eto T; Kusano F; Sakai Y
    Intern Med; 2019 Jan; 58(2):159-166. PubMed ID: 30210115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers.
    Arai M; Matsumura T; Okimoto K; Oyamada A; Saito K; Minemura S; Maruoka D; Tanaka T; Nakagawa T; Katsuno T; Yokosuka O
    World J Gastroenterol; 2014 Nov; 20(43):16318-22. PubMed ID: 25473190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Delayed Ulcer Healing after Endoscopic Submucosal Dissection of Gastric Neoplasms.
    Shimozato A; Sasaki M; Ogasawara N; Funaki Y; Ebi M; Tamura Y; Izawa S; Hijikata Y; Yamaguchi Y; Kasugai K
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):363-368. PubMed ID: 29253050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study.
    Ko J; Kim SJ; Kang DH; Choi CW; Kim HW; Park SB
    Medicine (Baltimore); 2019 May; 98(20):e15701. PubMed ID: 31096515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia.
    Komori H; Ueyama H; Nagahara A; Akazawa Y; Takeda T; Matsumoto K; Matsumoto K; Asaoka D; Hojo M; Yao T; Watanabe S
    J Int Med Res; 2019 Apr; 47(4):1441-1452. PubMed ID: 30816056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial.
    Tsuchiya I; Kato Y; Tanida E; Masui Y; Kato S; Nakajima A; Izumi M
    Dig Endosc; 2017 Jul; 29(5):576-583. PubMed ID: 28267236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection.
    Niimi K; Fujishiro M; Goto O; Kodashima S; Minatsuki C; Hirayama I; Mochizuki S; Ono S; Yamamichi N; Kakushima N; Ichinose M; Koike K
    Dig Endosc; 2012 Mar; 24(2):110-6. PubMed ID: 22348835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Tegoprazan on the Treatment of Endoscopic Resection-Induced Artificial Ulcers: A Multicenter, Randomized, Active-Controlled Study.
    Kim BW; Park JJ; Moon HS; Lee WS; Shim KN; Baik GH; Lim YJ; Lee HL; Youn YH; Park JC; Sung IK; Chung H; Moon JS; Kim GH; Hong SJ; Choi HS
    Gut Liver; 2024 Mar; 18(2):257-264. PubMed ID: 38384180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
    Kajiura S; Hosokawa A; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
    BMC Res Notes; 2015 Apr; 8():150. PubMed ID: 25889379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of administration of a proton pump inhibitor before endoscopic submucosal dissection for differentiated early gastric cancer with ulcer.
    Myung YS; Hong SJ; Han JP; Park KW; Ko BM; Lee MS
    Gastric Cancer; 2017 Jan; 20(1):200-206. PubMed ID: 26661593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of administration of a proton pump inhibitor for ulcerative differentiated early gastric cancer prior to endoscopic submucosal dissection.
    Wang J; Shan F; Li S; Li Z; Wu Q
    Dig Endosc; 2021 Sep; 33(6):939-947. PubMed ID: 33184984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Vonoprazan-Treated Patients after Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Multicenter Observation Study.
    Ishida T; Dohi O; Yamada S; Yasuda T; Yamada N; Tomie A; Tsuji T; Horii Y; Majima A; Horie R; Fukui A; Zen K; Tomatsuri N; Yagi N; Naito Y; Itoh Y
    Digestion; 2021; 102(3):386-396. PubMed ID: 32585678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mucoprotective agents in endoscopic submucosal dissection-derived ulcers: A systematic review.
    Pittayanon R; Martel M; Barkun A
    J Gastroenterol Hepatol; 2018 Dec; 33(12):1948-1955. PubMed ID: 29870582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study.
    Asakuma Y; Kudo M; Matsui S; Okada M; Kawasaki M; Umehara Y; Ichikawa T; Kitai S
    Hepatogastroenterology; 2009; 56(94-95):1270-3. PubMed ID: 19950775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study.
    Lee SH; Lee CK; Chung IK; Shim YS; Lee TH; Lee SH; Kim HS; Park SH; Kim SJ
    Dig Dis Sci; 2012 Feb; 57(2):429-34. PubMed ID: 22001942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
    Shin WG; Kim SJ; Choi MH; Kim KO; Jang HJ; Park CH; Baek IH; Kim KH; Baik GH; Kae SH; Kim JH; Kim HY
    Gastrointest Endosc; 2012 Apr; 75(4):739-47. PubMed ID: 22281110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial.
    Yoshizawa Y; Sugimoto M; Sato Y; Sahara S; Ichikawa H; Kagami T; Hosoda Y; Kimata M; Tamura S; Kobayashi Y; Osawa S; Sugimoto K; Miyajima H; Furuta T
    Dig Endosc; 2016 Mar; 28(2):162-72. PubMed ID: 26331711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection.
    Fujiwara S; Morita Y; Toyonaga T; Kawakami F; Itoh T; Yoshida M; Kutsumi H; Azuma T
    J Gastroenterol; 2011 May; 46(5):595-602. PubMed ID: 21359522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.